Will NVIDIA Return to Its 52-Week High?
NVIDIA (NASDAQ:NVDA) has been among the best-performing investments of the…
Sell
10
VTGN Quote, Financials, Valuation and Earnings
Last price:
$2.10
Seasonality move
:
-8.1%
Day range:
$2.01 - $2.12
52-week range:
$1.90 - $5.36
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
90.34x
P/B ratio:
0.75x
Volume:
41.7K
Avg. volume:
133.9K
1-year change:
-60.04%
Market cap:
$61.2M
Revenue:
$1.1M
EPS (TTM):
-$1.58
Earnings Data
Next earnings date for VTGN
Jun 11
2025
Most recent earnings per share
-$0.46
Beat by $0.06
(Feb 13/2025)
Consensus Estimate
-$0.52
(Feb 13/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
VTGN Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 06/30/2025 | Q2 | -- | -- | -- | -$0.32 | -- |
| 06/11/2025 | Q1 | $182K | -- | -- | -$0.49 | -- |
| 02/13/2025 | Q4 | $179.3K | $234K | -$0.46 | -$0.52 | $0.06 |
| 11/07/2024 | Q3 | $33.3K | $183K | -$0.42 | -$0.38 | -$0.04 |
| 08/13/2024 | Q2 | $298.5K | $84K | -$0.35 | -$0.41 | $0.06 |
| 06/11/2024 | Q1 | $202.8K | $197K | -$0.35 | -$0.33 | -$0.02 |
| 02/13/2024 | Q4 | $544.5K | $411.4K | -$0.22 | -$0.27 | $0.05 |
| 11/09/2023 | Q3 | -- | -- | -$0.66 | -$0.68 | $0.02 |
| 08/10/2023 | Q2 | -- | -- | -$0.94 | -$0.86 | -$0.08 |
| 06/23/2023 | Q1 | -- | -- | -$1.69 | -$1.50 | -$0.19 |
| 02/07/2023 | Q4 | -- | -- | -$1.42 | -$1.80 | $0.38 |
| 11/10/2022 | Q3 | -- | -- | -$2.54 | -$0.60 | -$1.94 |
| 08/11/2022 | Q2 | -- | -- | -$2.87 | -$2.25 | -$0.62 |
| 06/23/2022 | Q1 | -- | -- | -$2.58 | -- | -- |
| 02/10/2022 | Q4 | -- | -- | -$1.50 | -- | -- |
| 11/10/2021 | Q3 | -- | -- | -$2.10 | -- | -- |
| 08/12/2021 | Q2 | -- | -- | -$1.20 | -- | -- |
| 06/29/2021 | Q1 | -- | -- | -$4.91 | -- | -- |
| 02/11/2021 | Q4 | -- | -- | -$2.10 | -- | -- |
| 11/12/2020 | Q3 | -- | -- | -$1.50 | -- | -- |
| 08/13/2020 | Q2 | -- | -- | -$2.10 | -- | -- |
| 06/29/2020 | Q1 | -- | -- | -$2.10 | -- | -- |
| 02/13/2020 | Q4 | -- | -- | -$4.50 | -- | -- |
| 11/07/2019 | Q3 | -- | -- | -$3.90 | -- | -- |
| 08/13/2019 | Q2 | -- | -- | -$4.50 | -- | -- |
| 06/25/2019 | Q1 | -- | -- | -$4.50 | -- | -- |
| 02/12/2019 | Q4 | -- | -- | -$7.20 | -- | -- |
| 10/29/2018 | Q3 | -- | -- | -$9.00 | -- | -- |
| 08/14/2018 | Q2 | -- | -- | -$6.00 | -- | -- |
| 06/26/2018 | Q1 | -- | -- | -$5.68 | -- | -- |
| 02/12/2018 | Q4 | -- | -- | -$7.50 | -- | -- |
| 09/30/2017 | Q3 | -- | -- | -$15.90 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | -$8.40 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$9.30 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | -$10.20 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | -$12.60 | -- | -- |
| 06/30/2016 | Q2 | -- | -- | -$15.30 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -$108.90 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | -$58.50 | -- | -- |
| 09/30/2015 | Q3 | -- | -- | -$157.80 | -- | -- |
| 06/30/2015 | Q2 | -- | -- | -$576.90 | -- | -- |
Vistagen Therapeutics Earnings Questions
-
How Much did Vistagen Therapeutics Generate in Revenue Last Quarter?
Vistagen Therapeutics reported $234K worth of top line sales in its most recent quarter.
-
Did Vistagen Therapeutics Beat Earnings Last Quarter?
Vistagen Therapeutics announced earnings per share of -$0.46 which represents a beat of analyst forecast a -$0.52 per share.
-
Is Vistagen Therapeutics Profitable?
Vistagen Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Vistagen Therapeutics EPS Next Year?
Vistagen Therapeutics's earnings are forecast to decrease from -$1.52 per share to -$1.34 per share next year representing a decrease of -14.15%.
-
When is Vistagen Therapeutics's Earnings Date?
Vistagen Therapeutics's next earnings date is June 11, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will JP Morgan’s AI Advisor Be a Winner?
JPMorgan Chase is rolling out “JPM WealthAI for high-net-worth clients.…
Is Revolve Group Stock a Buy, Sell or Hold?
Recently, Revolve Group (NYSE:RVLV) management delivered some fairly positive business…
Stock Ideas
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
50
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
52
RGC alert for Apr 12
Regencell Bioscience Holdings [RGC] is up 29.14% over the past day.
Buy
52
SLP alert for Apr 12
Simulations Plus [SLP] is up 26.73% over the past day.
Buy
89
GDXU alert for Apr 12
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 15.9% over the past day.
